IM Cannabis Closes $1.2M Convertible Note With 15% Discount and 3.9M Warrants
IMCC is trading near its 52-week low of $0.66 (8.6% above the low).
Summary
IM Cannabis closed a US$1,200,000 convertible note with an existing institutional investor, issued at a 15% original issuance discount. The note carries 4% interest (14% on default), matures in 28 months, and converts at the lower of US$0.610 or 85% of the lowest 20-day VWAP, with a US$0.1449 floor. The company also handed over 3,936,330 warrants exercisable at US$0.610, immediately exercisable and expiring November 3, 2029. This is the latest in a string of small, dilutive raises — following the US$250,000 note in August, the US$225,000 note in September, and the US$1.31M registered direct offering at US$2.00 per share in late September — against a market cap near US$1.2 million and a stock at about $0.72. The 15% discount and warrant coverage mean meaningful dilution for existing holders, and the company can request up to another US$1,200,000 per three-month period starting January 1, 2027. Proceeds go to general corporate purposes; the company must file a resale registration statement on Form F-3 for the underlying shares.
At the time of this announcement, IMCC was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.2M. The 52-week trading range was $0.66 to $62.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.